Mir-221/222 are promising targets for innovative anticancer therapy.

导出原文传递

翻译打印收藏纠错

作者： Maria Teresa,Di Martino ^[1] ; Marco,Rossi ^[1] ; Daniele,Caracciolo ^[1] ; Annamaria,Gullà ^[1] ; Pierosandro,Tagliaferri ^[1] ; Pierfrancesco,Tassone ^[1]

作者单位： a Department of Experimental and Clinical Medicine , Magna Graecia University, Salvatore Venuta University Campus , Catanzaro , Italy. ^[1] b Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology , Temple University , Philadelphia , PA , USA. ^[2]

关键词 MicroRNA cancer miR-221 miR-221/222 miRNA miRNA inhibitors myeloma oligonucleotide-based therapy

主题词动物(Animals);人类(Humans);微RNAs(MicroRNAs);肿瘤(Neoplasms);RNA加工, 转录后(RNA Processing, Post-Transcriptional);RNA, 未翻译(RNA, Untranslated);增量调节(Up-Regulation)

DOI 10.1517/14728222.2016.1164693

PMID 26959615

发布时间 2022-03-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交